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ABSTRACT: The design and development of the first asymmetric aza-silyl-Prins reaction is reported, giving rise to valuable and 
diverse piperidines and pipecolic acid derivatives in both high yields and as single enantiomers.  The creation of a novel chiral 
auxiliary-homoallylic amine for the aza-silyl-Prins reaction is essential to its success. 
Chiral functionalized piperidine heterocycles are distributed 
widely in nature and as scaffolds for the pharmaceutical indus-
try, being the most common nitrogen-containing heterocycle in 
marketed drugs.1  Methods for their synthesis are wide ranging 
and have recently been reviewed.2 
The aza-silyl-Prins (ASP) reaction is a highly efficient and 
high yielding synthesis of tetrahydropyridines, starting from a 
vinylsilane-containing homoallylic amine, aldehyde and Lewis 
acid (Scheme 1).3-10  The reaction proceeds via an iminium ion 
intermediate and silicon -stabilised secondary carbocation.  
After elimination, the resultant alkene serves as a convenient 
handle for further functionalization.  The methodology has been 
utilized in a number of total syntheses.11  Methods for the asym-
metric synthesis of heterocycles via chiral iminium ion cyclisa-
tions have been reviewed.12  However, while the ASP reaction 
is highly diastereoselective for the 2,6-trans isomer, the one sig-
nificant drawback of the method to date has been the lack of an 
asymmetric version.  In 2016, List reported a catalytic asym-
metric Prins reaction to produce pyrans using a novel class of 
highly confined imino-imidodiphosphate Brønsted acids, in 
high yields and up to 95.5:4.5 e.r.13,14  However there remains 
no general asymmetric variant of the aza-Prins reaction to yield 
enantiopure piperidines.  Herein we report the first examples of 
an asymmetric aza-Prins reaction, giving rapid access to six-
membered nitrogen heterocycles as a single enantiomer. 
Scheme 1. The aza-silyl-Prins reaction.3,4 
 
It is possible to envisage several approaches to the develop-
ment of an asymmetric ASP reaction, including the use of chiral 
Lewis acid/ligand complexes or employing auxiliaries in the 
starting material(s). 
We first studied the use of chiral Lewis acid complexes 
(Scheme 2).  We have previously reported extensive Lewis acid 
screening to promote the ASP reaction, finding that InCl3 and 
FeCl3 were the most efficient and high yielding.
3,4,11  Therefore 
we investigated the use of chiral ligands around these Lewis ac-
ids.  Disappointingly, no combination gave any enantiomeric 
excess, although yields of the racemic mixture were consistent 
with those obtained in the absence of the ligand (Scheme 2a).15 
 Scheme 2. Attempted asymmetric ASP reactions using chiral 
Lewis acid complexes. 
 
The underlying principle of using chiral Lewis acid com-
plexes relies on forming a chiral iminium ion intermediate.  
These results suggest that the Lewis acid is only involved in 
promoting iminium ion formation and does not provide a chiral 
intermediate during the cyclisation process.  In order to furnish 
such a chiral complex, we investigated pre-forming an imine 
and activating this by the addition of a Lewis acid.  In this way, 
the chiral complex would still be present during the cyclisation 
(Scheme 2b).  Reaction optimization was first conducted in the 
racemic series.15  Only three compounds, InCl3, In(OTf)3 and 
Sc(OTf)3, gave reasonable yields of tetrahydropyridines, but re-
quiring lengthy reaction times at high temperature.  For purifi-
cation purposes, it was easier to trap the tetrahydropyridine as 
its CBz-derivative.  Four ligands were next prepared and em-
ployed in the proposed chiral Lewis acid-mediated imine-vi-
nylsilane cyclisation: (S)-(i-Pr)-PYBOX, (S)-(i-Pr)-(Ph)4-
PYBOX,[6] (R)-BINOL and (S)-BINOL, all based on their abil-
ity to coordinate to In- and Sc-based halides and triflates.16-32  
Initially, the imine derived from 2-naphthaldehyde was used, as 
the product CBz-derivative was the easiest to follow by chiral 
hplc.  None of the indium complexes gave any product; all the 
scandium triflate complexes gave product in low to modest 
yields, the best combination being Sc(OTf)3/(S)-(i-Pr)-
PYBOX/acetonitrile/reflux/120 hours, but only as a racemic 
mixture.  The same outcomes were observed using the imines 
derived from benzaldehdye or cyclohexanecarboxaldehyde.  In 
summary, while chiral scandium-based Lewis acids are capable 
of promoting vinylsilane-imine cyclisations, there is no ob-
served enantiomeric excess. 
Therefore the second approach, employing a chiral auxiliary 
was investigated.  Racemic and optically active auxiliaries have 
been employed in iminium ion-type cyclisations, with modest 
success.33-36  Our original studies on the ASP reaction employed 
the N-benzyl secondary amine (1, Scheme 1 and 2a).  A number 
of chiral amines are commercially available, and four were spe-
cifically prepared (Scheme 3). 
Scheme 3. Preparation of a variety of chiral secondary amines. 
 
These were screened in a number of ASP reactions (Table 1).  
Modest yields and low %d.e. were observed with the -methyl 
and -ethyl derivatives (Table 1 entries 1-4), with an improve-
ment observed when benzyl was changed to naphthyl (entry 5).  
The best diastereoselectivity (60%d.e.) was observed employ-
ing the amine with the additional chelating oxygen (Table 1, 
entry 6). 
Table 1. Selectivity in the chiral auxilliary-ASP reaction 
 
en-
try] 
R Ar R1 % yield[a] %d.e. 
1 Me Ph n-Pn 36 26 
2 Me Ph Bn 53 12 
3 Me Ph Ph 45 31 
4 Et Ph Ph 23 18 
5 Me Naphth Ph 40 50 
6 CH2OMe Ph CO2Et 62 60 
[a] isolated and purified yields 
The observation with the –CH2OCH3 auxiliary presented the 
opportunity of a new approach, designing a novel chiral auxil-
iary based on the cross-nitrogen diastereoselectivity observed 
in Scheme 1, and tethering this to the -benzyl chiral auxiliary 
(Scheme 4).  Thus compounds of the generic structure 2 were 
targeted. 
Scheme 4. Rational design of novel chiral auxiliary for ASP reac-
tion. 
 
 The new cyclic chiral auxiliary was prepared in 3 steps start-
ing from either (R)- or (S)-phenylglycinol (3, Scheme 3).37  Both 
series of enantio-complementary starting materials were pre-
pared and utilized throughout the study.  N-alkylation, Boc-pro-
tection and acid-catalysed cyclisation gave enantiopure phenyl-
substituted morpholinone (4).  Deprotonation with LHMDS fol-
lowed by various allylic or propargylic halides gave the cis- or 
trans- vinyl- (5 and 6) or alkynyl- (7) silanes as single enantio-
mers after TFA-promoted Boc deprotection. 
Scheme 5. Preparation of a variety chiral secondary amines (per-
formed on both (S)-3 and (R)-3). 
 
Vinylsilane (6, R=H) was used in a broad screening of Lewis 
acids.15  Only ZnCl2 and InCl3 gave cyclisation products.  Zinc 
chloride was particularly efficient at promoting the ASP reac-
tion, giving bicyclic compounds in high yields and as single di-
astereomers and enantiomers (Table 2 entries 1-5).  The reac-
tion also proceeded well when employing acetals or epoxides in 
place of the aldehyde, albeit in slightly lower yields (Table 2 
entries 6-7).  Utilising indium trichloride tetrahydrate also gave 
a single diastereomer and enantiomeric product, but this was 
different from the product obtained with zinc chloride.  Rather 
than elimination of the silane, water trapping of the intermediate 
carbocation was observed (Table 2 entries 8-9).  Indium trichlo-
ride tetrahydrate did not promote the reaction with epoxides 
(Table 2 entry 11) and in lower yields with acetals (entry 10).  
The unusual structure of (9a, Table 2, entry 8) was confirmed 
by x-ray crystallography.38  In all examples, the use of the op-
posite enantiomer of phenylglycinol the opposite enantiomeric 
product, in identical yields. 
Table 2. The aza-silyl-Prins reaction 
 
en-
try 
aldehyde[a] Lewis acid time 
/hr 
prod-
uct[b] 
%yield[c] 
1 Butanal ZnCl2 12 8a 83
[d] 
2 Decanal ZnCl2 12 8b 81 
3 Propanal ZnCl2 12 8c 80 
4 Phenylacetaldehyde ZnCl2 12 8d 82 
5 Ethyl glyoxalate ZnCl2 12 8e 85 
6 Cinnamaldehyde ZnCl2 12 8f 0
[d] 
7 CH3(CH2)2CH(OEt)2 ZnCl2 12 8a 65 
8 Styrene oxide ZnCl2 24 8d 57 
9 Butanal InCl3.4H2O 12 9a 81 
10 Propanal InCl3.4H2O 12 9b 80 
11 CH3(CH2)2CH(OEt)2 InCl3.4H2O 36 9c 43 
12 Styrene oxide InCl3.4H2O 36 9d 0
[e] 
[a] Typical procedure: aldehyde (or acetal or epoxide, 1 mmol); amine 
(1 equiv.), Lewis acid (1 equiv.) in dichloromethane (20 ml). [b] all 
products isolated as a single enantiomer (chiral shift NMR and chiral 
hplc) and in the case of 9a-d >99% single diastereomer.  [c] isolated and 
purified yield; all compounds gave satisfactory spectroscopic data. [d] 
comparable yields (5%) and single enantiomer/diatereomers obtained 
in opposite enantiomeric series.  [d] rapid decomposition.  [e] no reac-
tion. 
To expand the scope of the asymmetric ASP reaction, we have 
also investigated the use of allylsilanes in the reaction (Scheme 
4).39  
Scheme 6. Use of allylsilanes in the asymmetric ASP reaction. 
 
Although the Boc-protected compound (10) was stable, the 
corresponding secondary amine was highly unstable; attempted 
deprotection using TFA gave both the deprotected and de-si-
lylated compound in 73% yield.  Therefore a simultaneous 
deprotection-cyclisation protocol was attempted using TFA 
(Scheme 4, conditions 1) and butanal.  An unexpected tertiary 
alcohol product (11) was obtained as the only characterisable 
product in 56% yield.  Again the instability of the allylsilane 
under the reaction conditions is believed to be responsible, with 
desilylation occurring prior to Prins cyclisation, meaning –OH 
trapping of the tertiary carbocation becomes a facile process.  
Neither Sc(OTf)3 nor BF3.OEt2 were capable of performing the 
first Boc-deprotection step.  TMSOTf was found to be more ef-
ficient at promoting the simultaneous deprotection/ASP reac-
tion sequence.  Although very slow at -78 ⁰C, warming to -40 
⁰C proved more fruitful with the asymmetric ASP reaction oc-
curring to give an inseparable mixture of three alkene isomers 
in modest yield, but as single diastereisomers in each case, and 
consistent with the previous observed results (Table 2). 
Martin et al have recently reported the alkyne-Prins and al-
kyne-aza-Prins reactions.40-45  Therefore we have extended the 
methodology to the asymmetric alkyne-ASP reaction (Table 3). 
 Table 3. The alkyne aza-silyl-Prins reaction 
 
 
en
tr
y 
aldehyde Lew
is 
acid 
sol-
vent 
tim
e 
/hr 
prod
uct 
X=[b] %y
ield
[b,c] 
1 Butanal InCl
3 
DCM 12 13a Cl 80[
d] 
2 Decanal InCl
3 
DCM 12 13b Cl 78 
3 Ph(CH2)2CHO InCl
3 
DCM 12 13c Cl 81 
4 PhCH2CHO InCl
3 
DCM 12 13d Cl 83 
5 CH3(CH2)2CH(OE
t)2 
InCl
3 
DCM 24 13a Cl 78 
6 Styrene oxide InCl
3 
DCM 24 13d Cl 57 
7 Butanal InBr
3 
DBM 12 13e Br 85 
8 Ph(CH2)2CHO InBr
3 
DBM 12 13f Br 86 
9 PhCH2CHO InBr
3 
DBM 12 13g Br 83 
10 CH3(CH2)2CH(OE
t)2 
InBr
3 
DBM 24 13e Br 80 
11 Styrene oxide InBr
3 
DBM 24 13g Br 62 
a] Typical procedure: aldehyde (or acetal or epoxide, 1 mmol); amine (1 
equiv.), Lewis acid (1 equiv.) in dichloromethane (20 ml). [b] all products 
isolated as a single enantiomer (chiral shift NMR).  [c] isolated and purified 
yield; all compounds gave satisfactory spectroscopic data. [d] comparable 
yields (5%) and single enantiomer/diastereomers obtained in opposite en-
antiomeric series. 
The optimized conditions from the ASP reaction were ini-
tially applied to the alkyne-APR reaction employing butanal 
and gave the chloro-alkene TMS-substituted product in an ex-
cellent 80% and as a single enantiomer (Table 3 entry 1).  It was 
also possible to prepare the corresponding bromo-substituted 
(Table 3 entry 7) product using indium tribromide and dibro-
momethane as the solvent (to avoid mixed halogen products).43  
The scope of the cyclisation was further demonstrated by em-
ploying additional aldehyde (entries 2-4, 8 & 9), and also ace-
tals (entries 5 & 10) and epoxides (entries 6 & 11), although 
again the overall yields with acetals and epoxides were slightly 
lower.  The reaction surprisingly did not work with benzalde-
hyde with either Lewis acid, but did proceed well with aromatic 
functions on a distal position relative to the carbonyl group.  
The structure and stereochemistry was again confirmed by x-
ray crystallography (entry 7).46 
Elaboration and/or deprotection of the product heterocycles 
from both ASP and alkyne-ASP reactions would provide a fac-
ile route to enantiopure pipecolic acids.  Pipecolic acid is a non-
proteinogenic amino acid, derived from lysine metabolism and 
found as a secondary metabolite in numerous plants and fungi.  
Existing methods for the synthesis of pipecolic acid and its de-
rivatives have been reviewed,47 and it is surprising that there 
have only been limited approaches to pipecolic acid derivatives 
via Prins reaction-type approaches.48-50 
Catalytic hydrogen using Pearlman’s catalyst (Scheme 5a) 
simultaneously removed the chiral auxiliary and reduced the al-
kene to give enantiopure 6-substituted pipecolic acid deriva-
tives (14) in excellent yields.  The alkene moiety, however, had 
been designed into the products to be more useful than for sim-
ple reduction.  Catalytic dihydroxylation using OsO4/NMO 
gave the corresponding diol (15), again as a single enantiomer, 
in 95% yield and >99:1 dr, with the diol on the opposite face to 
the substituent derived from the aldehyde (Scheme 5b).  With-
out purification, this could be subjected to global hydrogenation 
to remove the chiral auxiliary and gave the 4,5-dihydroxy-6-
substituted pipecolic acid (16) derivative as a single enantiomer 
in 78% yield (75% for the two steps), offering a route to novel 
aza-sugars. 
Scheme 7. Alkene Functionalistion and deprotection. 
  
Reaction of the hydroxyl-TMS products from Table 2 with 
aqueous hydroiodic acid cleaved the TMS group (17) and gave 
4-hydroxypipecolic acid derivatives after removal of the auxil-
iary (18, Scheme 7).  Two alternative de-silylation reagents, HF 
and TBAF, both gave decomposition.  TMS-substituted pipe-
colic acid derivatives (19) could also be obtained from the same 
starting materials via catalytic hydrogenation. 
Scheme 8. Preparation of 4-hydroxypipecolic acid derivatives. 
 
 Hydrogenation of the halogenated products from Table 3 sim-
ultaneously removed the alkene and halogen, as well as the chi-
ral auxiliary, furnishing novel 5-TMS substituted pipecolic ac-
ids (20).  The same starting materials could also be reduced to 
the 6-substituted pipecolic acids by a combination of the hy-
droiodic acid methodology (21) followed by catalytic hydro-
genation (22, Scheme 8). 
Scheme 9. Preparation of a variety chiral secondary amines. 
 
In conclusion, we have reported the first examples of an 
asymmetric aza-silyl-Prins reaction, giving rise to piperidines 
and pipecolic acid derivatives, in high yields and as a single en-
antiomer.  Applications of the methodology are currently being 
investigated and will be reported in due course. 
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